{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:39:20Z","timestamp":1790735960034,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["308723\/2013-9 and 449436\/2014-4"],"award-info":[{"award-number":["308723\/2013-9 and 449436\/2014-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de Ensino Superior"},{"name":"NENASC Project","award":["1262\/2012-9"],"award-info":[{"award-number":["1262\/2012-9"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.euroneuro.2016.03.009","type":"journal-article","created":{"date-parts":[[2016,3,27]],"date-time":"2016-03-27T06:14:56Z","timestamp":1459059296000},"page":"959-971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Agmatine produces antidepressant-like effects by activating AMPA receptors and mTOR signaling"],"prefix":"10.1016","volume":"26","author":[{"given":"Vivian Binder","family":"Neis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgana","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Eduardo B.","family":"Bettio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille M.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila Batista","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipe Marques","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark William","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Bainy","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana L\u00facia S.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2016.03.009_bib1","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2174\/1381612053764814","article-title":"AMPA receptor potentiators as novel antidepressants","volume":"11","author":"Alt","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib2","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1124\/mol.58.4.802","article-title":"Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466","volume":"58","author":"Arai","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1146\/annurev.pharmtox.011008.145634","article-title":"Akt\/GSK3 signaling in the action of psychotropic drugs","volume":"49","author":"Beaulieu","year":"2009","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib6","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/mp.2010.44","article-title":"Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression","volume":"16","author":"Bernard","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrn1846","article-title":"New approaches to antidepressant drug discovery: beyond monoamines","volume":"7","author":"Berton","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bbr.2012.06.021","article-title":"Guanosine produces an antidepressant-like effect through the modulation of NMDA receptors, nitric oxide-cGMP and PI3K\/mTOR pathways","volume":"2","author":"Bettio","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib9","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/mp.2011.47","article-title":"Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice","volume":"16","author":"Beurel","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib10","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nn.3355","article-title":"Local potentiation of excitatory synapses by serotonin and its alteration in rodent models of depression","volume":"16","author":"Cai","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.pnpbp.2012.08.001","article-title":"Reduced phosphorylation of the mTOR signaling pathway components in the amygdala of rats exposed to chronic stress","volume":"40","author":"Chandran","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib12","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1096\/fj.08-106450","article-title":"AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression","volume":"22","author":"Chourbaji","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib13","doi-asserted-by":"crossref","first-page":"e33057","DOI":"10.1371\/journal.pone.0033057","article-title":"In vivo manganese exposure modulates Erk, Akt and Darpp-32 in the striatum of developing rats, and impairs their motor function","volume":"7","author":"Cordova","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib14","doi-asserted-by":"crossref","unstructured":"Cunha, M.P., Budni, J., Ludka, F.K., Pazini, F.L., Rosa, J.M., Oliveira, A., Lopes, M.W., Tasca, C.I., Leal, R.B., Rodrigues, A.L., Involvement of PI3K\/Akt signaling pathway and its downstream intracellular targets in the antidepressant-like effect of creatine. Mol. Neurobiol. 2016, (in press). 10.1007\/s12035-015-9192-4","DOI":"10.1007\/s12035-015-9192-4"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00726-014-1910-0","article-title":"The modulation of NMDA receptors and L-arginine\/nitric oxide pathway is implicated in the anti-immobility effect of creatine in the tail suspension test","volume":"4","author":"Cunha","year":"2015","journal-title":"Amino Acids"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib16","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1176\/appi.ajp.2011.11010128","article-title":"Monitoring ketamine treatment response in a depressed patient via peripheral mammalian target of rapamycin activation","volume":"168","author":"Denk","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.31887\/DCNS.2014.16.1\/rduman","article-title":"Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections","volume":"16","author":"Duman","year":"2014","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/187152707780619317","article-title":"Depression","volume":"6","author":"Duman","year":"2007","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuropharm.2011.08.044","article-title":"Signaling pathways underlying the rapid antidepressant actions of ketamine","volume":"62","author":"Duman","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib20","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1001\/archpsyc.60.8.804","article-title":"Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects","volume":"60","author":"Dwivedi","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib21","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1038\/sj.npp.1301641","article-title":"Lower phosphoinositide 3-kinase (PI 3-kinase) activity and differential expression levels of selective catalytic and regulatory PI 3-kinase subunit isoforms in prefrontal cortex and hippocampus of suicide subjects","volume":"33","author":"Dwivedi","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib22","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.biopsych.2012.11.011","article-title":"Activation of mammalian target of rapamycin and synaptogenesis: role in the actions of rapid-acting antidepressants","volume":"73","author":"Dwyer","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1017\/S1461145711001702","article-title":"mTOR activation is required for the antidepressant effects of mGluR(2)\/(3) blockade","volume":"15","author":"Dwyer","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib24","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1523\/JNEUROSCI.4733-03.2004","article-title":"Postsynaptic density 95 controls AMPA receptor incorporation during long-term potentiation and experience-driven synaptic plasticity","volume":"24","author":"Ehrlich","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib25","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1073\/pnas.0609307104","article-title":"PSD-95 is required for activity-driven synapse stabilization","volume":"104","author":"Ehrlich","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nn997","article-title":"PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity","volume":"6","author":"Esteban","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.pnpbp.2008.10.005","article-title":"Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression","volume":"33","author":"Feyissa","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jpsychires.2014.07.024","article-title":"Sub-chronic agmatine treatment modulates hippocampal neuroplasticity and cell survival signaling pathways in mice","volume":"58","author":"Freitas","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib29","doi-asserted-by":"crossref","unstructured":"Freitas, A.E., Egea, J., Buendia, I., Gomez-Rangel, V., Parada, E., Navarro, E., Casas, A.I., Wojnicz, A., Ortiz, J.A., Cuadrado, A., Ruiz-Nuno, A., Rodrigues, A.L., Lopez, M.G., Agmatine, by improving neuroplasticity markers and Inducing Nrf2, prevents corticosterone-Induced depressive-like behavior in mice. Mol. Neurobiol. 2016b (in press). 10.1007\/s12035-015-9182-6","DOI":"10.1007\/s12035-015-9182-6"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib30","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-015-9182-6","article-title":"Agmatine, by improving neuroplasticity markers and inducing Nrf2, prevents corticosterone-induced depressive-like behavior in mice","author":"Freitas","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neubiorev.2015.03.005","article-title":"The role of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in depression: central mediators of pathophysiology and antidepressant activity?","volume":"52","author":"Freudenberg","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib32","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pnpbp.2007.07.027","article-title":"Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus","volume":"32","author":"Garcia","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib33","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1017\/S1461145704004535","article-title":"AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test","volume":"7","author":"Gould","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib34","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.brainres.2005.01.007","article-title":"Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects","volume":"1037","author":"Hoshaw","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib35","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.pnpbp.2011.05.010","article-title":"The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder","volume":"35","author":"Jernigan","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib36","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.biopsych.2006.04.036","article-title":"Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims","volume":"61","author":"Karege","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib37","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1017\/S1461145705005316","article-title":"Involvement of nitric oxide-cGMP pathway in the antidepressant-like effects of adenosine in the forced swimming test","volume":"8","author":"Kaster","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib38","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.neuropharm.2011.08.018","article-title":"Depressive-like behavior induced by tumor necrosis factor-alpha in mice","volume":"62","author":"Kaster","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib39","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.neuron.2009.01.015","article-title":"Synaptic AMPA receptor plasticity and behavior","volume":"61","author":"Kessels","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1523\/JNEUROSCI.20-01-00008.2000","article-title":"Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons","volume":"20","author":"Lauterborn","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib41","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0092-8674(03)00122-3","article-title":"Phosphorylation of the AMPA receptor GluR1 subunit is required for synaptic plasticity and retention of spatial memory","volume":"112","author":"Lee","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib42","first-page":"1","article-title":"BDNF release is required for the behavioral actions of ketamine","author":"Lepack","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib43","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.biopsych.2010.12.015","article-title":"Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure","volume":"69","author":"Li","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib44","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib45","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.biopsych.2011.09.030","article-title":"Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex","volume":"71","author":"Liu","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib46","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1038\/npp.2013.128","article-title":"GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine","volume":"38","author":"Liu","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pharmthera.2009.02.010","article-title":"Ketamine and the next generation of antidepressants with a rapid onset of action","volume":"123","author":"Machado-Vieira","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0028-3908(02)00066-7","article-title":"An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study","volume":"43","author":"Mackowiak","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib49","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11920-007-0063-1","article-title":"The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects","volume":"9","author":"Maeng","year":"2007","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib50","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1471-4159.2002.00939.x","article-title":"BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents","volume":"82","author":"Mai","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib52","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2165\/11595900-000000000-00000","article-title":"The hippocampus, neurotrophic factors and depression possible implications for the pharmacotherapy of depression","volume":"25","author":"Masi","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib53","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.biopsych.2012.09.006","article-title":"The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine","volume":"73","author":"Monteggia","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib54","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpsychires.2013.10.014","article-title":"Antidepressant-like effect of ascorbic acid is associated with the modulation of mammalian target of rapamycin pathway","volume":"48","author":"Moretti","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib55","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbr.2013.12.038","article-title":"Depressive-like behavior induced by tumor necrosis factor-alpha is abolished by agmatine administration","volume":"261","author":"Neis","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pbb.2014.12.009","article-title":"Agmatine enhances antidepressant potency of MK-801 and conventional antidepressants in mice","volume":"130","author":"Neis","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib57","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/sj.bjp.0702679","article-title":"Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor","volume":"127","author":"Olmos","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib58","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2004"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib59","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0003-2697(77)90043-4","article-title":"A simplification of the protein assay method of Lowry et al. which is more generally applicable","volume":"83","author":"Peterson","year":"1977","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib60","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.drudis.2013.05.017","article-title":"Agmatine: clinical applications after 100 years in translation","volume":"18","author":"Piletz","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib61","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00204-007-0177-6","article-title":"Exposure of C6 glioma cells to Pb(II) increases the phosphorylation of p38(MAPK) and JNK1\/2 but not of ERK1\/2","volume":"81","author":"Posser","year":"2007","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib62","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/jmr.2401","article-title":"ConBr, a lectin from Canavalia brasiliensis seeds, modulates signaling pathways and increases BDNF expression probably via a glycosylated target","volume":"27","author":"Rieger","year":"2014","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib63","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.pnpbp.2008.05.020","article-title":"Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice","volume":"32","author":"Rosa","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib64","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrd2462","article-title":"Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders","volume":"7","author":"Sanacora","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib65","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/1073858410384740","article-title":"AKAP signaling complexes in regulation of excitatory synaptic plasticity","volume":"17","author":"Sanderson","year":"2011","journal-title":"Neuroscientist"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib66","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ddstr.2008.10.003","article-title":"Future antidepressant targets: neurotrophic factors and related signaling cascades","volume":"5","author":"Schmidt","year":"2008","journal-title":"Drug Discov. Today Ther. Strateg."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib67","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neuroscience.2011.07.007","article-title":"Spatial learning-induced accumulation of agmatine and glutamate at hippocampal CA1 synaptic terminals","volume":"192","author":"Seo","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib68","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1523\/JNEUROSCI.22-08-03251.2002","article-title":"Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression","volume":"22","author":"Shirayama","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib69","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0091-3057(96)00169-4","article-title":"Antidepressant-like effect of brain-derived neurotrophic factor (BDNF)","volume":"56","author":"Siuciak","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib70","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(99)00330-1","article-title":"Antidepressants for the new millennium","volume":"375","author":"Skolnick","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib71","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test - a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib72","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.neuropharm.2015.08.026","article-title":"Activation of mTOR dependent signaling pathway is a necessary mechanism of antidepressant-like activity of zinc","volume":"99","author":"Szewczyk","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib73","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.brainres.2006.02.024","article-title":"Agmatine protects against cell damage induced by NMDA and glutamate in cultured hippocampal neurons","volume":"1084","author":"Wang","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib501","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/35072566","article-title":"Research and treatment approaches to depression","volume":"2","author":"Wong","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib74","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.biopsych.2012.07.022","article-title":"Acute increases in plasma mammalian target of rapamycin, glycogen synthase kinase-3beta, and eukaryotic elongation factor 2 phosphorylation after ketamine treatment in three depressed patients","volume":"73","author":"Yang","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib75","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1002\/j.1460-2075.1990.tb07564.x","article-title":"Activity dependent regulation of BDNF and NGF mRNAs in the rat hippocampus is mediated by non-NMDA glutamate receptors","volume":"9","author":"Zafra","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib76","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib77","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/hipo.20593","article-title":"Positive modulation of AMPA receptors prevents downregulation of GluR2 expression and activates the Lyn-ERK1\/2-CREB signaling in rat brain ischemia","volume":"20","author":"Zhang","year":"2010","journal-title":"Hippocampus"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib78","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1023\/A:1025069407173","article-title":"Effect of agmatine against cell death induced by NMDA and glutamate in neurons and PC12 cells","volume":"23","author":"Zhu","year":"2003","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.euroneuro.2016.03.009_bib79","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00001756-200203250-00005","article-title":"Agmatine produces antidepressant-like effects in two models of depression in mice","volume":"13","author":"Zomkowski","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.euroneuro.2016.03.009_bib80","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.brainres.2004.07.041","article-title":"Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test","volume":"1023","author":"Zomkowski","year":"2004","journal-title":"Brain Res."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X16300074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X16300074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T09:08:20Z","timestamp":1718442500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X16300074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":81,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0924977X16300074"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2016.03.009","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Agmatine produces antidepressant-like effects by activating AMPA receptors and mTOR signaling","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2016.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}